Stockreport

Press Release: Sanofi's Teizeild recommended for EU approval by the CHMP for patients with stage 2 type 1 diabetes [Yahoo! Finance]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF Recommendation based on the TN-10 study, demonstrating Teizeild's ability to delay the onset of stage 3 type 1 diabetes (T1D), compared to placebo, in adults and childr [Read more]